SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

Day One Says Mid-Stage Trial of Glioma Drug Achieves Positive Initial Results, Will Expand Development

MT Newswires · 06/12/2022 23:27

Please log in to view news